The global capnography devices market was valued at USD 676.6 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2030. This growth is expected to be driven by several key factors, including ongoing technological advancements, an increasing prevalence of respiratory conditions, and strong support from government initiatives aimed at improving healthcare outcomes. Capnography devices, which monitor the concentration of carbon dioxide (CO2) in exhaled air, are becoming increasingly integral in managing respiratory diseases. Their proven reliability and efficiency in real-time patient monitoring are expected to further enhance their adoption, improving clinical outcomes.

For example, chronic obstructive pulmonary disease (COPD), which includes conditions such as emphysema and chronic bronchitis, affects a significant portion of the population. In 2022, it was reported that 4.6% of adults had been diagnosed with one of these conditions at some point in their lives. Furthermore, 4.2% of office-based physician visits included COPD as a documented condition, and there were approximately 791,000 emergency department visits where COPD was the primary reason for seeking medical care. The rising burden of these conditions highlights the increasing demand for effective tools, such as capnography devices, to monitor and manage respiratory health.

Technological innovations in capnography are also contributing to the market's growth. The development of portable and handheld capnography devices, which offer enhanced accuracy and better integration with other monitoring systems, has expanded the range of clinical applicatioQns. These innovations are making capnography devices more user-friendly and accessible for healthcare providers across various settings. For instance, in June 2022, Medtronic introduced a new solution that combines its INVOS regional oximetry (rSO2) with Microstream capnography (CO2) technologies, enabling personalized patient care. This integration was incorporated into the GE Healthcare CARESCAPE precision monitoring platform, which has been used to improve care in both perioperative and intensive care unit (ICU) environments. This integration of technologies has the potential to significantly enhance patient outcomes, further driving the growth of the global capnography devices market.

Gather more insights about the market drivers, restrains and growth of the Capnography Devices Market

Regional Insights

The North America capnography devices market led the global market in 2023. The region’s dominance can be attributed to the rising prevalence of respiratory diseases, which are largely driven by unhealthy lifestyle habits and high levels of stress. These factors are the primary drivers of demand for capnography devices in North America. Furthermore, the introduction of new reimbursement models for respiratory and monitoring solution procedures is expected to further boost market growth in the region. These models are designed to support healthcare providers by improving access to advanced monitoring technologies. In addition to these financial incentives, stringent regulatory guidelines in North America, which emphasize patient safety, medical efficacy, and clinical efficiency, are also contributing to the increased demand for capnography devices. The American Psychological Association's 2020 survey found that 49% of U.S. adults reported that stress had negatively impacted their behavior, with 21% experiencing heightened bodily tension as a result. This growing awareness of the impact of stress on health is likely to drive the need for more effective respiratory monitoring tools.

U.S. Capnography Devices Market Trends

In 2023, the U.S. capnography devices market held a dominant share of 88.7% within the North American market. This high market share is largely driven by the increasing prevalence of respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea, all of which contribute to a higher demand for continuous respiratory monitoring systems. For instance, the American Lung Association launched a Research Institute in 2023, committing to an annual investment of USD 25 million for lung disease research. This move underscores the U.S. healthcare system's growing focus on respiratory diseases and the need for advanced medical technologies, including capnography devices, to address these issues.

Europe Capnography Devices Market Trends

In Europe, the capnography devices market was identified as a promising and lucrative region in 2023. Capnography is essential in clinical settings for verifying endotracheal tube placement and distinguishing between successful and failed intubations. As such, the demand for these devices is expected to rise, particularly in emergency and surgical care. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cancer, is driving the need for more efficient medication delivery and monitoring systems, further fueling the market's growth. According to the World Health Organization (WHO), COPD is the fifth most common cause of death in Europe, with smoking being the most significant risk factor contributing to the rise in COPD cases.

• United Kingdom (UK): The UK capnography devices market is expected to experience rapid growth in the coming years. The increased use of capnography devices in emergency departments, critical care units, and ambulatory settings is driving this growth. These devices, known for their high specificity and sensitivity, are now mandatory in the UK for confirming endotracheal tube placement and for managing cardiac arrest cases. This regulatory shift is likely to further accelerate the adoption of capnography devices across healthcare settings.
• Germany: The Germany capnography devices market held a substantial market share in 2023, driven by the country’s large patient population suffering from respiratory conditions such as sleep apnea, asthma, and COPD. These conditions are expected to continue driving the demand for capnography devices, which are crucial for monitoring respiratory function and ensuring optimal patient care.

Asia Pacific Capnography Devices Market Trends

The Asia Pacific capnography devices market is poised for significant growth. Several factors are contributing to this growth, including the increasing demand for efficient respiratory monitoring systems and the introduction of new, innovative products designed to treat respiratory diseases in countries like India and China. In May 2022, Max Ventilator introduced multipurpose noninvasive ventilators with built-in humidifiers in India, which are expected to support the growing need for respiratory care in the region.

• Japan: The Japan capnography devices market is expected to grow rapidly in the coming years due to the increasing adoption of capnography devices in various healthcare settings. The growing number of surgical procedures in Japan is driving the demand for capnography devices, as they are critical for monitoring patients during anesthesia and surgery. Additionally, the introduction of innovative capnography devices is expected to help companies gain a larger share of the market.
• China: The China capnography devices market held a significant market share in 2023, primarily due to the rising incidence of respiratory conditions, particularly cancer. A 2022 study by the China Pulmonary Health survey found that the incidence of spirometry-defined COPD among adults was 8.6%, affecting nearly 100 million people. As China continues to face a growing burden of respiratory diseases, the demand for capnography devices is expected to rise, further cementing the country’s position as a key market in the Asia Pacific region.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global electrophysiology devices market size was estimated at USD 12.9 billion in 2024 and is projected to grow at a CAGR of 15.1% from 2025 to 2030.
• The global preclinical CRO market size was valued at USD 5.72 billion in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024 to 2030.

Key Capnography Devices Company Insights

Some of the key companies in the capnography devices market include Smiths Medical (acquired by ICU Medical Inc.), Dragerwerk AG & Co. KGaA, Baxter, Masimo, Koninklijke Philips N.V., Medtronic, Nonin, NIHON KOHDEN CORPORATION, BD, Diamedica (UK) Limited, and EDAN Instruments, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies. 

• Smiths Medical, a division of the UK-based Smiths Group plc, is a global manufacturer of specialty medical devices serving various healthcare sectors such as critical care, anesthesia, and oncology. The company operates in over 50 countries and markets its products to more than 100 countries, catering to hospitals, clinics, and home care settings.
• Dragerwerk AG & Co. KGaA is an international company specializing in medical and safety technology, offering neonatal, intensive, prenatal, and emergency care solutions. Their product range includes monitoring, ventilation, anesthetics, warming therapy, and information management systems.

Key Capnography Devices Companies:

The following are the leading companies in the capnography devices market. These companies collectively hold the largest market share and dictate industry trends.

• Smiths Medical (acquired by ICU Medical Inc.)
• Dragerwerk AG & Co. KGaA
• Baxter
• Masimo
• Koninklijke Philips N.V.
• Medtronic
• Nonin
• NIHON KOHDEN CORPORATION
• BD
• Diamedica (UK) Limited
• EDAN Instruments, Inc.

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.